Government regulation is needed to prevent biased under-reporting of clinical trials

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.462-a (Published 19 August 2004) Cite this as: BMJ 2004;329:462
  1. Iain Chalmers, editor, James Lind Library (ichalmers@jameslindlibrary.org)
  1. James Lind Initiative, Oxford OX2 7LG

    EDITOR—In 1996, Schering Healthcare published details of its ongoing randomised clinical trials in the Cochrane Library. The chief executive told me that he was doing this because industry's failure to disclose the results of its phase 3 trials could not be defended ethically or scientifically. Two years later, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial